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Abstract
Complex human diseases commonly differ in their phenotypic characteristics, e.g., Crohn’s disease (CD) patients are
heterogeneous with regard to disease location and disease extent. The genetic susceptibility to Crohn’s disease is
widely acknowledged and has been demonstrated by identification of over 100 CD associated genetic loci. However,
relating CD subphenotypes to disease susceptible loci has proven to be a difficult task. In this paper we discuss the
use of cluster analysis on genetic markers to identify genetic-based subgroups while taking into account possible
confounding by population stratification. We show that it is highly relevant to consider the confounding nature of
population stratification in order to avoid that detected clusters are strongly related to population groups instead of
disease-specific groups. Therefore, we explain the use of principal components to correct for population stratification
while clustering affected individuals into genetic-based subgroups. The principal components are obtained using 30
ancestry informative markers (AIM), and the first two PCs are determined to discriminate between continental origins
of the affected individuals. Genotypes on 51 CD associated single nucleotide polymorphisms (SNPs) are used to
perform latent class analysis, hierarchical and Partitioning Around Medoids (PAM) cluster analysis within a sample of
affected individuals with and without the use of principal components to adjust for population stratification. It is seen
that without correction for population stratification clusters seem to be influenced by population stratification while
with correction clusters are unrelated to continental origin of individuals.
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Introduction
Many human diseases have a complex genetic architecture
and differ in their expression of symptoms. Such phenotypic
variability, i.e., variation in the phenotypic expression of one
underlying disease, has important consequences for the
treatment of affected individuals. For example, Crohn’s disease
(CD) patients vary with regard to disease severity, behaviour
and location. Classification of inflammatory bowel disease
(IBD) cases into similar groups of patients is highly relevant to
determine the appropriate mode of therapy delivery and care
intensity per patient group [1,2]. So far, existing classification
rules for Crohn’s disease have mainly been based on
phenotypic clinical measurements [3]. However, under the
impulse of the International IBD Genetics Consortium (IIBDGC)
and other research groups world-wide, an increasing
knowledge about genetic predisposing factors for IBD has
become available [4,5]. A meta-analysis of 15 genome-wide
association studies (GWAS) and Immunochip data has recently
identified 163 loci associated to IBD, of which 30 loci were
uniquely associated to Crohn’s disease while 23 loci were
ulcerative-colitis-specific [5].
Previous efforts to link associated genetic markers with
classic clinical CD subphenotypes have detected a clear
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association between NOD2/CARD15 variants and ileal disease
location [6-8]. For other clinical subphenotypes, no robust
association with disease susceptibility genes could be shown.
This raises the questions of whether more sophisticated and
powerful strategies are required to link IBD genetic loci to
known clinical subphenotypes, or whether latent (yet to define)
patient groups exist that are driven by molecular mechanisms.
In earlier work of our research group, a first attempt has
been made to reclassify CD patients based on single-
nucleotide polymorphisms (SNPs) via model-based cluster
analysis [9]. Although significantly different genetic-based
subgroups could be found, only modest differences between
these groups with regard to clinical subphenotypes were
described. Our results led to a plea to identify and use
molecular information for improved disease risk prediction and
disease classification [1], but at the same time highlighted
some important issues to consider during the classification
process [9].
One important issue is the assessment of how disease-
specific identified molecular groups are and to what extent
these groups overlap with general population strata. It is widely
acknowledged that population stratification, which refers to
varying allele frequencies between subpopulations in the study
population due to different ancestries, is a confounding factor in
GWAS leading to spurious association results and failure to
detect true associations when not properly accounted for [10].
In this paper, we therefore focus on the effect of population
stratification on the classification and on methods to correct for
population stratification when clustering affected individuals
into genetic-based groups.
Cluster analysis of individuals based on SNPs has been
performed with different purposes, e.g., the detection of
genetic-based patient groups, the dissection of trait
heterogeneity or the identification of disease susceptible SNPs
[9,11-13]. To our knowledge, confounding by population
stratification has largely been neglected in any of these
analyses. The ignorance of population stratification for cluster
analysis of individuals based on genetic data is quite surprising
for two reasons.
Firstly for population stratification as for the clustering
purposes described above, similar, if not the same, resources
(i.e., genetic markers) and analysis methods are used. Indeed,
latent class analysis as applied in Cleynen et al. [9] to detect
genetic-based subgroups has also been proposed to detect
population stratification [14]. Latent class analysis is
methodologically similar to the model-based cluster analysis
implemented in the software STRUCTURE for investigation of
population stratification and can thus be classified as structured
association method [9,15]. Other authors have suggested
hierarchical clustering and the k-means algorithm to detect
population structure which can subsequently be taken into
account for association studies [16,17].
Secondly, the non-consideration of population stratification is
surprising since Myles et al. [18] indicated that some disease
risk alleles show an unusual high differentiation between
populations to the extreme of being entirely absent in a
population. The reason for these strong differences in allele
frequencies at certain disease associated markers may be
geographically-restricted positive natural selection [18]. Thus,
using a set of disease predisposing markers to classify affected
individuals into genetic-based subgroups can likely be
confounded by population stratification. For example, Myles et
al. [18] described that SNP rs10761659, which is associated to
Crohn’s disease, gave rise to extremely elevated Fst values for
pairwise comparisons of African and non-African populations.
In other words, an unusual high differentiation in allele
frequency between African and non-African populations was
observed for this SNP. More subtle differences may also exist
in allele frequencies for disease predisposing markers between
European populations, e.g., for the SNP rs916977. This SNP is
located in the HERC2 gene known to be involved in iris colour
and to show population stratification in Europe [19], but the
HERC2 gene has also been reported to be associated with
Crohn’s disease in a Dutch-Belgian cohort study [20].
In this research paper, we apply several cluster analysis
methods on available data for Crohn’s disease to study the
complex architecture underlying Crohn’s disease by identifying
genetic-based groups. We illustrate the necessity to adjust
such a cluster analysis for population substructure and give
leads on how to do this with minimal genotyping costs in the
absence of a genome-wide SNP panel. In particular, we
suggest the use of principal components to correct SNPs for
population stratification prior to the cluster analysis. Principal
components are commonly used as covariates in logistic or
linear regression analysis for genome-wide association studies
to handle confounding by population stratification. Similarly to
our approach, Zhao et al. [21] regressed the SNPs using
principal components to correct for population stratification
before performing a random forest analysis. After the cluster
analysis, we studied the obtained homogeneous genetic-based
patient groups or clusters further to detect association with
commonly used clinical subphenotypes.
Methods
Data.
Patients .  A total of 845 CD patients were recruited from six
paediatric and adult gastroenterology tertiary centres. The
diagnosis of IBD was based on Lennard-Jones criteria [22].
Patients were included between April 2002 and October 2003 if
the diagnosis of CD was done at least one year before
inclusion and if the patients had a continuous follow-up in the
reference centres. Patients affected by a disease treated by
chemotherapy or radiotherapy were excluded. The study
received an ethical agreement of the French national ethic
committee “Comité de Protection des Personnes” from Hôpital
Saint Louis, Paris, France. All participants signed a written
informed consent for their information to be stored in the
hospital database and used for research.
Recorded phenotypic criteria.   Clinical, endoscopic and
radiologic data were retrospectively collected and phenotypic
items were validated by the referent expert gastroenterologist
of the patients [2]. The involvement of ileum and colon was
registered at diagnosis and at the end of follow-up. Behaviour
was summarised into a binary variable following the Montreal
classification (B1: non-stricturing, non-penetrating disease; non
Molecular Classes and Population Stratification
PLOS ONE | www.plosone.org 2 October 2013 | Volume 8 | Issue 10 | e77720
B1: stricturing and/or penetrating disease) [3]. Furthermore,
information on frequency of hospitalisation,
immunosuppressive medication (yes/no), surgery (yes/no) and
age at diagnosis were available. Frequency of hospitalisation
was categorised into never, intermediate frequency and often.
Age at diagnosis was classified into lower than 17 years, from
17 to 40 years and more than 40 years according to the
Montreal classification.
Genotyping.   Patients were genotyped for 51 earlier
reported CD susceptibility SNPs using an AB17900HT
Sequence detection system Illumina GoldenGate assay
(Illumina, San Diego, CA) by the Centre National de
Génotypage (CNG, Evry, France) and by IntegraGen (Evry,
France). For each SNP the genotyping call rate was higher
than 75% except for SNPs rs2631367, rs1050152 and
rs2188962 which had a call rate of around 50%. Around 86% of
all SNPs had a genotyping call rate higher than 0.8 and around
30% of all SNPs had a genotyping call rate higher than 0.9. For
each analysed SNP, we used the following convention of
nomenclature: 0 for the homozygotes carrying the frequent
allele, 1 for the heterozygotes and 2 for homozygotes carrying
the rare allele.
Furthermore, a subset of 450 cases was selected for
additional genotyping on 30 ancestry informative markers by
IntegraGen (Evry, France) to infer about population
stratification and to reduce missing population information.
More details on the population information can be found below.
The 30 ancestry informative markers (AIMs) were selected
since they were found to best discriminate with regard to FST
between European, African and South-East Asian ancestries in
both HapMap 2 and Human Genome Diversity Project. The call
rate of the 30 ancestry markers was higher than 95%. The 450
individuals were chosen based several criteria: 1) non-
European self-reported population background to maintain
population diversity in the sample, 2) missing self-reported
population information to reduce missing knowledge about
population, 3) previous DNA quality, e.g., high call rate.
Population information.  On the initial data set with 845
individuals self-reported information was available regarding
the continental origin (Europe, Asia and Africa ) of individuals
and of their parents. Subjects were assigned to admixed origin
if continental origin of father and mother differed. The majority
of individuals, namely 677 (80.12%) were of European origin
(see Table 1). The rest of the sample consisted of six admixed
individuals (0.71%), six African individuals (0.71%), five Asian
(0.59%) and 151 individuals (17.87%) with missing information
(see Table 1).
For the subset of 450 individuals, who were genotyped on
the panel of 30 ancestry informative markers, self-reported
population or missing population information was replaced by
population information obtained from the ancestry informative
markers. This ancestry marker-based population information
was derived from a PAM cluster analysis combining the 450
individuals with a HapMap 3 reference panel consisting of
individuals with European, Sub-Saharan Africa or East Asian
population background. The cluster analysis was performed
using Euclidean distance on the 30 ancestry markers for the
combined data set. All HapMap 3 individuals, who had the
same population, agreed also in their PAM cluster assignment.
The decision that one of the 450 individuals belonged to a
given population, that is Europe, Sub-Saharan Africa or East
Asia, was then based on the assigned PAM cluster. For each
individual its silhouette width was determined which provides a
measure of how well the individual fits into its attributed
population.
Within the sample of 450 individuals, 430 subjects (95.56%)
were from European ancestry (Table 1). Only three subjects
(0.67%) were determined to be of East Asian ancestry, and 17
subjects (3.78%) were Sub-Saharan African. Self-reported
population information was available from 356 subjects in the
subset of 450 individuals and agreed with information derived
from the AIMs for 346 individuals (97.19%). Four admixed
individuals were attributed to the population of one of their
parents as would be expected, while one admixed subject with
Asian and European parents was assigned to Sub-Saharan
Africa. Using the combined information from self-reports and
AIMs, population information is missing in 57 subjects of the
total study sample of 845 subjects (7%) instead of 151
individuals as based on the self-reports. In the following we will
speak of the combined population information to refer to the
joint information provided by self-reports and ancestry markers.
Statistical analysis
Several cluster analyses were performed, i.e., model-based
clustering via a latent class analysis, partitional cluster analysis
using Partitioning Around Medoids algorithm and hierarchical
cluster analysis using an agglomerative approach. Our focus
was on commonly applied cluster analysis methods which
provided an implementation in R allowing for missing data.
Furthermore, the latent class analysis was chosen since it had
been previously applied by Cleynen et al. [9]. Investigating in
detail the performance of various different clustering analysis
methods for molecular disease classification efforts was
beyond the scope of this paper.
Partitioning methods identify a user specified number of
clusters and assign each element to their closest cluster based
on a distance measure. These methods need to be
supplemented with a procedure to choose the most optimal
number of clusters. In contrast, hierarchical methods involve
constructing a tree of clusters in which the tree root is a single
cluster containing all the observations and the leaves contain
Table 1. Population information in study sample.
 Population based on ancestry informative markers 
Self-reported
population East Asia Europe Sub-Saharan Africa Missing Total
Admixed 1 3 1 1 6
Africa 0 0 5 1 6
Asia 0 3 1 1 5
Europe 0 341 1 335 677
Missing 2 83 9 57 151
Total 3 430 17 395 845
doi: 10.1371/journal.pone.0077720.t001
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each only one observation. Agglomerative hierarchical
methods (bottom-up) start with each individual defining its own
cluster and merge cluster progressively according to a linkage
criteria, e.g., complete-linkage, single-linkage or Ward’s
method. The latter joins the two clusters that will produce the
smallest increase in the pooled within-cluster variation and is
based on using the squared Euclidean distance.
As opposed to the aforementioned algorithmic approaches to
cluster analysis, latent class analysis is a model-based cluster
analysis method that offers a variety of model selection tools
and probability based classification through a posterior
probability of class membership. This approach avoids the
selection of an ad hoc dissimilarity or distance measure. In the
following description we describe the application of latent class
analysis and the use of more traditional cluster analysis
methods on our available data set in separate sections.
Latent Class Analysis.  A latent class analysis was
performed on the 51 CD associated SNPs within CD cases.
Latent class analysis was applied using Latent GOLD Version
4.5 assuming binomial count variables. Missing data was
handled by using the available information for each subject in
the parameter estimation for the latent class model assuming
that data is missing at random [23]. The number of latent
classes K was determined using a bootstrap procedure and
likelihood ratio (LR) testing of the null hypothesis that the
population is best explained by N classes versus the alternative
hypothesis with N + 1 classes. Per latent class model, 500
bootstrap samples were generated. Individuals were assigned
into their class based on the highest membership probability
obtained from the latent class analysis. Influential SNPs for a
given class within the final latent class model were assessed
via Z-scores as provided by the Latent GOLD software. All
formal testing was performed at a nominal significance level of
0.05.
Principal component analysis.  The available panel of 30
ancestry informative markers were submitted to a principal
components analysis in the R-package snpStats version 1.8.1
and R-version 2.15.3 [24]. Prior to the principal component
computation, the matrix G=(gij)i=1,...,n,j=1,..,m containing the
genotypes gij (=0, 1 or 2) for an individual i (i=1, ... , n) at
marker j (j=1, ..., m) was standardised. Standardisation was
obtained by subtracting the column mean 2pj from each column
in G and by dividing each column by its standard deviation
2p j 1− p j , where pj is the estimated minor allele frequency of
marker j [25]. Missing genotypes were replaced by zeros in the
standardised matrix. Following Price et al. [26], a correction for
population stratification was then applied on the genotype
matrix G by projecting the genotypes onto the space
orthogonal to the space spanned by the principal components:
G'= In−A ATA −1AT G, (1)
where In is the identity matrix of size n and A is a n×kmatrix
containing (a subset of ) k principal components. Missing
genotypes in G are not taken into account for calculation of the
population stratification adjusted genotypes G' and are set to
missing in G' as well.
Cluster analysis.  All 450 individuals were subsequently
clustered in R version 2.15.3 based on their population
stratification adjusted genotypes gij, using either hierarchical
agglomerative cluster analysis as implemented in the hclust
function or Partitioning Around Medoids (PAM) clustering
algorithm via the pamk function [27]. No model-based cluster
analysis was performed on the continuous population-adjusted
SNP data since this analysis would have been based on the
assumption of a Gaussian distribution for the variables. This
assumption was not justified here. The PAM algorithm was
applied using Euclidean distance and the average silhouette
width to determine the optimal number of clusters [28]. The
hierarchical cluster analysis was applied using Ward’s
minimum variance criterion and squared Euclidean distance.
For the hierarchical cluster analysis, the agglomeration criterion
values, which correspond here to the distance between the two
clusters joined at a given agglomeration step, were considered
to determine the number of clusters. The distance between two
clusters is proportional to the distance between their two
centroids. A strong increase in the agglomeration criterion
indicates that two dissimilar clusters are being joined and that
the agglomeration can be stopped at this step. The strength of
increase was evaluated by studying the percentage change in
agglomeration criterion when going from N + 1 clusters to N
clusters. For reasons of parsimony, we studied the percentage
change in the agglomeration criterion over the last ten
agglomeration steps. Both functions pamk and hclust were able
to handle missing data by considering only available data per
individual. When SNPs were excluded in the calculation of the
pairwise distance between two subjects, the distance was
scaled up proportionally to the number of SNPs used.
Furthermore, we applied the PAM clustering algorithm and
hierarchical cluster analysis directly on the population
unadjusted SNP variables of the 450 individuals to enable a
more direct comparison between the results on the adjusted
and non-adjusted SNP data by using similar methodology. As
before on the population adjusted SNPs, the Euclidean
distance was applied for the PAM algorithm while the squared
Euclidean distance and Ward’s minimum variance criterion
were used for the hierarchical cluster analysis.
Association testing of genetic-based subgroups and
clinical subphenotypes.  Association tests between clinical
subphenotypes and identified genetic-based groups were
performed in R 2.15.3 using univariate Fisher’s exact tests or
Pearson’s chi-squared tests (with or without bootstrap
sampling) depending on which method was most appropriate.
The similarity of the various groupings obtained by the cluster
analysis methods were compared pairwise to each other using
the adjusted Rand index (ARI). The adjusted Rand index is
bounded above by 1, where 1 indicates perfect agreement
between two groupings. Values of the adjusted Rand Index
above 0.9 can be seen as excellent agreement, values above
0.8 as good agreement and values greater than 0.65 can be
considered as moderate agreement, while values below 0.65
show poor agreement [29].
Molecular Classes and Population Stratification
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Results
Latent class analysis using population unadjusted SNP
data
Latent class analysis and bootstrap LR test on 51 CD-
associated SNPs identified nine classes in the 845 individuals.
A subset of 475 individuals (i.e., 56% ) had a class
membership probability higher than 0.9 for their assigned class
and hence a reliable assignment to one specific patient class
could be made for these individuals. For a total of 186 patients
(22%) the maximum class membership probability was lower
than 0.6. Nevertheless, these patients were assigned to their
most probable patient subgroup.
Table 2 shows the p-values of the association tests between
the classes and available clinical subphenotypes. When using
the latent class analysis, significant results (p < 0.05) were
obtained for the variables indicating terminal ileum disease
location. The classes differed thus most strongly with regard to
whether or not disease location at diagnosis was terminal ileum
but results were no longer significant after Bonferroni correction
for multiple testing. Class 6 and 8 contained the highest and
lowest proportion of individuals with terminal ileum disease
location, respectively (Table 3). In the previous statement,
class 5 and 9 are not taken into account since these classes
contained many individuals with missing information on the
clinical subphenotypes. Table 3 gives a complete
characterization of the CD patients in our data according to
clinical subphenotypes and latent classes.
Using the Z-scores obtained for each SNP variable and each
class within Latent GOLD, four SNPs had Z-scores significantly
different from zero for class 6 and were thus characteristic for
this class: rs2066847 (NOD2), rs2241880 (ATG16L1) and
rs17582416 (intergenic region on 10p11) and rs744166
(STAT3). Restricting to class 6 individuals, the minor alleles of
these SNPs showed the following frequencies based on the
latent class model: 0.997 for rs2066847 with minor allele C
(highest allele frequency of all classes), 0.1331 for rs2241880
with minor allele G (lowest allele frequency of all classes),
0.1907 for rs17582416 with minor allele G (lowest allele
frequency of all classes) and 0.5405 for rs744166 with minor
allele G (highest allele frequency of all classes).
The distribution of population strata (according to the
combined information) over the identified nine classes is
presented in Table 4. These results show that that all classes,
except class 8, were mostly populated by individuals with a
European background. Although only 17 of 845 patients
(2.01%) were assigned to class 8, the majority (70.59%) of
these 17 individuals were from Sub-Saharan Africa or Africa.
The association between the populations and the classes was
significant (Pearson’s chi-squared test with 99999 bootstrap
samples, p = 0.00001). The following two findings about two of
the four Europeans in class 8 seem to be in line with the mainly
African nature of class 8. Firstly, one individual in class 8,
which was assigned to Europe based on the AIMs and thus
represented as European in Table 4, was admixed with a
European and African parent based on self-report. Secondly,
one European individual in class 8 had only a class
membership probability of 0.61, which does not indicate a
strong class membership.
Principal component analysis
Figure 1 shows a scatterplot of 450 CD patients according to
the first two principal axes of genetic variation based on 30
ancestry SNPs. These two principal components PC1 and PC2
explained 18% of the variation captured by the 30 ancestry
SNPs and were considered in the next section to correct for
population stratification in the three ancestry-marker derived
populations (East Asia, Sub-Saharan Africa, and Europe).
Whereas PC1 differentiated between Europe and Non-Europe,
PC2 arguably seemed to discriminate between Africa and Asia.
There was one strong outlier, who despite being attributed to
Sub-Saharan Africa based on the set of 30 AIMs, had a PC2
value lower than all the East Asian individuals. The self-
reported origin of this individual was Africa and its silhouette
width for the assignment into Sub-Saharan Africa was 0.06.
This low silhouette width and the self-reported information
indicate that the subject is perhaps from Africa but might be
closer to North Africa than to Sub-Saharan Africa in its genetic
background.
Table 2. P-values for association testing of clusterings with
clinical subphenotypes.
 Population unadjusted data
Population adjusted
data
 
Latent
classes
PAM
clusters
Hierarchical
clusters
PAM
clusters
Hierarchical
clusters
Age at diagnosis
(Montreal) 0.2966 0.6213 0.9644 0.3799 0.3925
Disease location      
 Terminal ileumat diagnosis 0.0094 0.2539 0.5280 0.9124 0.8423
 Terminal ileumat follow-up 0.0291 0.0691 0.1674 0.8993 1.0000
 Colon atdiagnosis 0.9965 0.4964 0.3616 0.5751 0.0719
 Colon at follow-up 0.9774 0.2269 0.0636 0.8984 0.0670
Disease behaviour      
 Behaviour B1 atdiagnosis 0.0840 0.8815 0.7644 0.0569 0.6620
 Behaviour B1 atfollow up 0.5800 0.1412 0.5824 0.6860 0.7402
Frequency of
hospitalisation 0.4205 0.2270 0.2457 0.4672 0.0538
Immunosuppressive
medicaments 0.2318 0.9491 0.6560 0.8194 0.7629
Surgery 0.4659 0.2501 0.9623 0.3739 0.9447
doi: 10.1371/journal.pone.0077720.t002
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Cluster analysis of CD patients using population
adjusted und unadjusted SNP data
Using the PAM clustering algorithm on the population
adjusted SNP data within the subset of 450 individuals only two
clusters were found based on the silhouette width. The average
silhouette width was highest for two clusters with a value of
0.0112. However, such a low value for the average silhouette
width indicates an extremely low to non-existing structure in the
data. Individual silhouette widths for clusters varied between
-0.05 and 0.06 for cluster 1 and between -0.03 and 0.32 for
cluster 2. In general, a value close to zero indicates that an
individual is at the border between two clusters while a value
close to -1 indicates that the individual is better attributed to a
neighbouring cluster. No significant association between any
clinical subphenotype and the PAM clustering was found based
on Fisher’s exact test (see Table 2).
Using the hierarchical cluster analysis and population
adjusted SNP data, three clusters were detected in the 450
patients after visual inspection of the percentage change in the
agglomeration criterion as can be seen from Figure 2. The
percentage change was highest when joining three to two
clusters indicating that two quite dissimilar clusters were being
joined. Therefore, the agglomeration could better be stopped at
this stage. Table 2 shows that frequency of hospitalisation,
colon at diagnosis and colon at follow-up were nearly
significant based on Fisher’s exact test (p = 0.0538, p = 0.0719
and p = 0.0670, respectively). In Table 5 an overview of the
distribution of phenotypic characteristics over the hierarchical
Table 3. Characteristics of individuals in overall data set and in latent classes.
 Class 1 Class 2 Class 3 Class 4 Class 5 Class 6 Class 7 Class 8 Class 9 Total
Subjects 407 163 136 33 32 24 18 17 15 845
Age at diagnosis           
 <17 94 (24%) 53 (33%) 45 (33%) 5 (15%) 0 (0%) 9 (38%) 5 (28%) 8 (47%) 0 (0%) 219 (28%)
 17-40 276 (69%) 98 (61%) 79 (59%) 27 (82%) 1 (100%) 14 (58%) 11 (61%) 8 (47%) 1 (100%) 515 (65%)
 >=40 30 (8%) 10 (6%) 11 (8%) 1 (3%) 0 (0%) 1 (4%) 2 (11%) 1 (6%) 0 (0%) 56 (7%)
Disease location           
 Terminal ileum at diagnosis 251 (65%) 122 (77%) 99 (75%) 22 (67%) 1 (100%) 22 (92%) 14 (82%) 8 (53%) 1 (100%) 540 (71%)
 Terminal ileum at follow-up 307 (77%) 139 (86%) 116 (85%) 25 (76%) 1 (100%) 24 (100%) 16 (89%) 12 (71%) 1 (100%) 641 (81%)
 Colon at diagnosis 286 (74%) 115 (73%) 95 (73%) 25 (78%) 1 (100%) 17 (71%) 13 (76%) 13 (76%) 1 (100%) 566 (74%)
 Colon at follow-up 330 (83%) 129 (80%) 112 (83%) 26 (81%) 1 (100%) 20 (83%) 15 (88%) 14 (82%) 1 (100%) 648 (82%)
Disease behaviour           
 B1 at diagnosis 313 (80%) 120 (75%) 102 (77%) 26 (79%) 0 (0%) 14 (61%) 12 (67%) 16 (94%) 1 (100%) 604 (78%)
 B1 at follow-up 187 (48%) 67 (42%) 53 (40%) 14 (42%) 0 (0%) 8 (33%) 8 (44%) 7 (41%) 1 (100%) 345 (45%)
Frequency of hospitalisation           
 Never 62 (16%) 21 (13%) 19 (15%) 6 (19%) 0 (0%) 4 (17%) 3 (18%) 3 (18%) 0 (0%) 118 (15%)
 Intermediate 286 (74%) 125 (79%) 99 (76%) 23 (72%) 1 (100%) 19 (79%) 13 (76%) 10 (59%) 0 (0%) 576 (75%)
 Often 41 (11%) 13 (8%) 12 (9%) 3 (9%) 0 (0%) 1 (4%) 1 (6%) 4 (24%) 1 (100%) 76 (10%)
Immunosuppressive medicaments 297 (74%) 125 (77%) 102 (75%) 23 (70%) 1 (100%) 14 (58%) 9 (50%) 13 (76%) 1 (100%) 585 (74%)
Surgery 196 (49%) 87 (54%) 69 (51%) 17 (52%) 1 (100%) 17 (71%) 11 (61%) 9 (53%) 0 (0%) 407 (51%)
Class 5 contains 31 individuals with missing information on all clinical characteristics. Class 9 contains 14 individuals with missing information on all clinical characteristics.
For the other classes, the number of individuals with missing information differs between the clinical characteristics.
doi: 10.1371/journal.pone.0077720.t003
Table 4. Distribution of populations over clusters obtained by latent class analysis.
 Admixed Africa Asia East Asia Europe Sub-Saharan Africa Missing Total
Class 1 0 (0%) 0 (0%) 1 (0.25%) 1 (0.25%) 370 (90.91%) 4 (0.98%) 31 (7.62%) 407 (100%)
Class 2 1 (0.61%) 0 (0%) 0 (0%) 1 (0.61%) 146 (89.57%) 2 (1.23%) 13 (7.98%) 163 (100%)
Class 3 0 (0%) 0 (0%) 0 (0%) 0 (0%) 134 (98.53%) 0 (0%) 2 (1.47%) 136 (100%)
Class 4 0 (0%) 0 (0%) 0 (0%) 0 (0%) 31 (93.94%) 0 (0%) 2 (6.06%) 33 (100%)
Class 5 0 (0%) 0 (0%) 0 (0%) 1 (3.13%) 24 (75%) 0 (0%) 7 (21.88%) 32 (100%)
Class 6 0 (0%) 0 (0%) 0 (0%) 0 (0%) 24 (100%) 0 (0%) 0 (0%) 24 (100%)
Class 7 0 (0%) 0 (0%) 0 (0%) 0 (0%) 18 (100%) 0 (0%) 0 (0%) 18 (100%)
Class 8 0 (0%) 1 (5.88%) 0 (0%) 0 (0%) 4 (23.53%) 11 (64.71%) 1 (5.88%) 17 (100%)
Class 9 0 (0%) 0 (0%) 0 (0%) 0 (0%) 14 (93.33%) 0 (0%) 1 (6.67%) 15 (100%)
Total 1 (0.12%) 1 (0.12%) 1 (0.12%) 3 (0.36%) 765 (90.53%) 17 (2.01%) 57 (6.75%) 845 (100%)
doi: 10.1371/journal.pone.0077720.t004
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clusters and in the subset of 450 individuals is presented.
Table 5 shows that cluster 3 contained a lower percentage of
individuals with colon as disease location (33% at diagnosis
and 50% at follow-up) than the other clusters. Notably, neither
the PAM clusters nor the hierarchical clusters were significantly
associated with the population structure (Fisher’s exact test,
respectively p = 0.1392 and p = 0.4608 for PAM and
hierarchical agglomerative clustering).
Furthermore for comparison with the results above, we
applied PAM and hierarchical cluster analysis on the 51 CD
associated SNPs without adjustment for population
stratification within the subset of 450 individuals. For the PAM
clustering, the average silhouette width had a maximum value
of 0.03 for three clusters. This indicates that there is limited
structure in the data based on the PAM clustering. Fisher’s
exact test showed a significant association between the
ethnicity based population strata (East Asia, Sub-Saharan
Africa, and Europe) and the PAM clusters (p = 0.0002). The
majority of Sub-Saharan Africans in the data (65%) belonged to
PAM cluster 3 although PAM cluster 3 only represented 21% of
all 450 individuals.
For the hierarchical agglomerative clustering of patients, the
percentage change in the Ward agglomeration criterion, i.e.,
the squared Euclidean distance between the two clusters
joined at this step, was the highest when joining three to two
clusters (see Figure 3). Detailed inspection of the 3-cluster
solution highlights a significant association between the three
populations and the three hierarchical clusters using Fisher’s
exact test (p = 0.0005). In particular, 11 of the 17 Sub-Saharan
African individuals (65%) belonged to hierarchical cluster 2,
although this cluster contained only 98 of 450 individuals
(22%). No significant association could be found between the
Figure 1.  Principal components based on 30 ancestry
informative markers for 450 individuals.  
doi: 10.1371/journal.pone.0077720.g001
Figure 2.  Percentage change in agglomeration criterion
(hierarchical cluster analysis using population adjusted
SNPs).  
doi: 10.1371/journal.pone.0077720.g002
Table 5. Characteristics of individuals in subset of 450
individuals and in hierarchical clusters based on population
adjusted SNPs.
 Cluster 1 Cluster 2 Cluster 3 Total
Subjects 309 102 39 450
Age at diagnosis     
 <17 90 (29%) 25 (25%) 0 (0%) 115 (28%)
 17-40 194 (63%) 67 (66%) 6 (100%) 267 (64%)
 >=40 22 (7%) 10 (10%) 0 (0%) 32 (8%)
Disease location     
 Terminal ileum at diagnosis 209 (71%) 68 (69%) 4 (67%) 281 (70%)
 Terminal ileum at follow-up 249 (81%) 83 (81%) 5 (83%) 337 (81%)
 Colon at diagnosis 219 (74%) 69 (70%) 2 (33%) 290 (72%)
 Colon at follow-up 252 (83%) 79 (78%) 3 (50%) 334 (81%)
Disease behaviour     
 B1 at diagnosis 226 (76%) 79 (79%) 4 (67%) 309 (77%)
 B1 at follow-up 124 (42%) 46 (46%) 2 (33%) 172 (43%)
Frequency of hospitalisation     
 Never 41 (14%) 11 (11%) 1 (17%) 53 (13%)
 Intermediate 220 (76%) 80 (80%) 2 (33%) 302 (76%)
 Often 30 (10%) 9 (9%) 3 (50%) 42 (11%)
Immunosuppressive medicaments 229 (75%) 78 (76%) 4 (67%) 311 (75%)
Surgery 169 (55%) 55 (54%) 3 (50%) 227 (55%)
Cluster 1 contains three individuals with missing information on all clinical
characteristics. Cluster 3 contains 33 individuals with information missing on all
clinical characteristics. For cluster 2 each individual provides information for at
least one clinical characteristic.
doi: 10.1371/journal.pone.0077720.t005
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PAM clustering or hierarchical clustering for any of the
subphenotypes (see Table 2).
The adjusted Rand indexes were between 0.04 and 0.54
thus indicating a poor agreement of the different groupings with
each other (see Table 6). It seemed that the groupings based
on the unadjusted SNP agreed better with each other (ARIs
between 0.23 and 0.49) than with the groupings based on the
ancestry adjusted SNPs (ARIs between 0.04 and 0.23 except
for the two hierarchical clusterings which reached an ARI of
0.54). Notably, the PAM and hierarchical clustering based on
the adjusted SNP markers had a very low ARI of 0.04.
Discussion
Crohn’s disease is a complex disorder with heterogeneity in
disease symptoms, characteristics and development between
Figure 3.  Percentage change in agglomeration criterion
(hierarchical cluster analysis using population unadjusted
SNP markers).  
doi: 10.1371/journal.pone.0077720.g003
Table 6. Adjusted Rand Indexes between latent class
analysis (LCA), PAM clustering and hierarchical clustering
(HC) (using population unadjusted or adjusted SNP data).
  Unadjusted Adjusted
  LCA PAM HC PAM HC
Unadjusted LCA  0.49 0.30 0.12 0.23
 PAM   0.23 0.20 0.13
 HC    0.04 0.54
Adjusted PAM     0.04
 HC      
doi: 10.1371/journal.pone.0077720.t006
patients. Due to the validated genetic background of Crohn’s
disease it is of interest to assess the extent by which disease
susceptible markers can help to identify disease subtypes or
patient subgroups. In a first study, Cleynen et al. [9] applied
latent class analysis to molecularly reclassify CD patients
based on a selection of 46 markers identified from GWA
studies on CD and/or meta-analysis of these [4]. However, they
did not consider the potential interference between molecular
reclassification and population substructure. In this paper, we
proposed principal components to correct SNPs for population
stratification prior to cluster analysis and showed that quite
different results can be obtained while adjusting for or ignoring
population substructure.
It was seen that the adjusted Rand indexes were low thus
indicating little overlap between the different cluster analysis
methods even when applied on the same data source.
However, this might be expected since different cluster
analysis methods use different criteria for cluster formation and
can thus lead to different results [30]. Furthermore, the latent
class analysis was performed on the full study sample while the
other cluster analysis methods were applied only on the subset
of 450 individuals for comparison among each other. Another
reason for the little overlap in the groupings could be that there
was inherently little structure in the data as indicated by the low
silhouette widths for the PAM algorithm and the low percentage
of individuals with high maximum class membership probability.
The number of clusters varied also between the methods
although the PAM algorithm with average silhouette width and
the hierarchical cluster analysis with percent change in
agglomeration criterion seemed to agree in the fact that a lower
number of clusters was optimal. It should be mentioned that
using a Bayesian information criterion to determine the optimal
number of classes for the latent class analysis within the full
sample also led to only three clusters. For future research it will
be beneficial to perform a more detailed comparison of different
cluster analysis methods with regard to the identification of
genetic-based subgroups on larger data sets. However, the
focus in this paper was on the correction for population
stratification when identifying genetic-based disease subgroups
and not on the comparison of different cluster analysis
methods.
Association tests with the clusterings – before and after
correction for population using the principal components –
indeed revealed that, before correction, groupings were
significantly associated with population structure while after
correction no significant association could be detected. All
analysis methods on the population unadjusted data seemed to
have one group with a mainly African background. This shows
that, as expected, cluster analysis based on SNP data can be
confounded by population stratification. However, it was also
seen that the suggested approach of using the principal
components to obtain population adjusted SNP data solved the
issue of population stratification.
Despite our observation that latent classes of patients were
likely to be confounded by population stratification, the
significant associations found between terminal ileum at
diagnosis and the latent classes were interesting from several
perspectives. Relevant SNPs for the latent class with the
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highest percentage of terminal ileum at diagnosis were SNPs
rs2066847 (NOD2), rs2241880 (ATG16L1), rs17582416
(intergenic region on 10p11) and rs744166 (STAT3). Notably,
NOD2 has repeatedly been shown to be associated with
terminal ileum as disease location [6-8], and rs2241880 has
also been described as being associated with ileal disease
location [31,32]. Furthermore, two of these four SNPs, namely
rs2066847 and SNP rs2241880 are part of one pathway, the
autophagy pathway, previously reported to play a role in CD
disease pathogenesis [33]. Jung et al. [2] performed a
genotype/phenotype analysis using logistic regression on a
slightly different version of the data used in this paper and
could also detect an association of NOD2 variants with ileal
disease location. This agreement with previous results might
be seen as a confirmation that cluster analysis can be applied
to detect subphenotype associated variants.
When correcting for population stratification, evidence for a
significant association between terminal ileum and the
clusterings no longer existed, irrespective of whether
hierarchical or PAM algorithms were used. In contrast, the
hierarchical clustering showed an almost significant association
for disease location in the colon. None of the associations
reported here is however significant when corrected for multiple
testing using Bonferroni correction. Note that ignoring
population strata for the hierarchical or PAM cluster analysis
were also unable to establish significant associations between
genetic-based subgroups.
One explanation why an interesting result might have been
found when not correcting for confounding by population
stratification is the following. While risk alleles for CD at the
NOD2 locus are frequent in Caucasian populations, these risk
alleles are less frequent in African or Asian populations [34,35].
Not only might there be differences with regard to genotype
between races but also differences with regard to clinical
subphenotype, e.g., it seems that African Americans have less
frequently ileal disease location than Caucasians [36]. These
different prevalences for subphenotypes might be caused by
different allele frequencies due to ancestry. Similarly, Myles et
al. [18] imply that highly differentiated allele frequencies
between populations may lead to differences in disease
prevalence between populations. In such a case correcting for
population stratification will actually unwantedly remove
differences in allele frequencies so that subphenotypes
associated with these alleles cannot be detected anymore.
For future subphenotype analysis, it might thus be
recommendable to focus on populations with a similar genetic
background, e.g., Europeans, for a cluster analysis on genetic
markers. However, the main scope of this paper was not to
detect genetic-based groups associated with subphenotypes
but to study the effect of population stratification on the
detection of genetic-based subgroups and to describe the
benefits and potential limitations of principal components to
correct for population stratification. The use of principal
components in a regression framework is perhaps the most
popular method to correct for population stratification in genetic
association studies. Advantages of using principal components
instead of other methods to correct for population stratification
are computational efficiency and ease of use, although the
selection of principal components to include in the analysis is
often based on heuristics.
Other common methods to control for population stratification
in association studies are genomic control [37] and the
program STRUCTURE [15] . However, genomic control is not
applicable in our context since it directly corrects the potentially
inflated test statistics from an association study [37]. Using
STRUCTURE we would be able to separate our subjects into
several subpopulations and subsequently perform a cluster
analysis on each subpopulation. However, such a procedure
would lead to a reduction of the sample size for each analysis
and thus a loss of power. Furthermore, this approach would
ignore a clinal pattern of genetic variation in the data which can
be captured by principal components. Human genetic variation
has been argued to be better described by clinal patterns than
by partition into distinct subpopulations [38].
In this study, we used ancestry informative markers to
calculate the principal components enabling us to separate
continental populations. This is a useful approach for candidate
marker studies where information on population stratification
cannot be obtained from a genome-wide set of markers. The
additional sampling of ancestry markers is then a simple and
cost-effective alternative to detect population structure.
There are several reasons why we might not have been able
to find a strong association between the subphenotypes and
the detected clusters. Firstly, efforts should be undertaken to
repeat the analysis strategies on a much larger cohort to
improve power. Currently, analysis is ongoing to perform such
strategies on data consisting of ~ 19,000 Crohn’s disease
patients from The International IBD Genetics Consortium.
Secondly, using a larger number of CD associated variants,
e.g., all currently known 110 CD associated genetic markers,
might also improve the classification results. Thirdly, Cleynen
et al. [9] and Jung et al. [2] hypothesized that different genetic
variants might be relevant for discrimination between
subphenotypes than for discrimination between cases and
controls. Performing a genome-wide cluster analysis has the
advantage that such variants can be discovered.
Disadvantages of a genome-wide cluster analysis are the
increased computation time and the difficulty to find the set of
relevant genetic markers for subphenotypes within a huge set
of uninformative genetic markers. A future topic of research
could be to investigate the possibility of genome-wide cluster
analysis despite the massive computational effort and to
develop suitable methodology.
Further in-depth investigations are needed to prove the
suggested methodology based on simulated data. Simulation
studies could generate data with population structure using the
Balding-Nichols model [39] and additional structure due to
gene variants associated with subphenotypes. It is then
possible to evaluate the performance of several methods to
correct for population stratification, prior to or during different
cluster analyses, on data with known substructures. Such a
simulation study can also be useful to provide
recommendations on which cluster analysis methods would be
most efficient in discovering substructure based on genetic-
based patient subgroups after correction for population
stratification.
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To conclude, we showed that principal components can be
used to correct SNP data for population stratification before
performing a cluster analysis. While our focus has been on
Crohn’s disease, the presented methodology can be applied to
any complex heterogeneous disease. Furthermore, our aim
was to explore phenotypic variability by relating the detected
genetic-based groups to clinical subphenotypes, but Thornton-
Wells et al. [40] and Thornton-Wells et al. [11] suggested using
cluster analysis to unravel various other forms of heterogeneity,
e.g., trait heterogeneity and genetic heterogeneity as well.
Thus, the presented methodology to correct for population
stratification in cluster analysis of SNP data might also prove
useful for detection of other factors of heterogeneity in complex
human diseases.
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